Agne Paner
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 28
- Multiple Myeloma Research and Treatments 25
- Chronic Myeloid Leukemia Treatments 3
-
- Protein Degradation and Inhibitors 15
- Amyloidosis: Diagnosis, Treatment, Outcomes 4
- Histone Deacetylase Inhibitors Research 4
- Co-authors
- Paul G. Richardson (12 shared papers)Pritesh Patel (2 shared papers)Binod Dhakal (3 shared papers)Jesús G. Berdeja (2 shared papers)Parameswaran Venugopal (4 shared papers)Joachim Gullbo (2 shared papers)Eric K. Rowinsky (1 shared paper)Claudia E. Paba‐Prada (1 shared paper)
- Journals
- Blood (9 papers)HemaSphere (2 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesItalySpain
In The Last Decade
Agne Paner
32 papers receiving 278 citations
Peers
Comparison fields: 5 of 41
- Hematology 160
- Oncology 114
- Molecular Biology 217
- Genetics 31
- Pathology and Forensic Medicine 18
Countries citing papers authored by Agne Paner
This map shows the geographic impact of Agne Paner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agne Paner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agne Paner more than expected).
Fields of papers citing papers by Agne Paner
This network shows the impact of papers produced by Agne Paner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agne Paner. The network helps show where Agne Paner may publish in the future.
Co-authors
The 25 scholars most cited alongside Agne Paner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 73 | |
| 2 | 2015 | 29 | |
| 3 | 2014 | 29 | |
| 4 | 2019 | 28 | |
| 5 | 2020 | 15 | |
| 6 | 2018 | 11 | |
| 7 | 2019 | 10 | |
| 8 | 2020 | 9 | |
| 9 | 2021 | 8 | |
| 10 | 2018 | 7 | |
| 11 | 2019 | 7 | |
| 12 | 2018 | 7 | |
| 13 | 2021 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2018 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2018 | 3 | |
| 19 | 2019 | 3 | |
| 20 | 2009 | 3 |
About Agne Paner
Agne Paner is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Cardiology and Cardiovascular Medicine, having authored 33 papers that have together received 282 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (25 papers), Protein Degradation and Inhibitors (15 papers), Peptidase Inhibition and Analysis (8 papers), Chronic Lymphocytic Leukemia Research (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Cancer Treatment and Pharmacology (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Hematology (160 citations), Oncology (114 citations), Molecular Biology (217 citations), Genetics (31 citations) and Pathology and Forensic Medicine (18 citations). Agne Paner has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Paul G. Richardson, Pritesh Patel, Binod Dhakal, Jesús G. Berdeja, Parameswaran Venugopal, Joachim Gullbo, Eric K. Rowinsky, Claudia E. Paba‐Prada, Stig Linder and Kimmo Porkka. Their work appears in journals such as Blood, HemaSphere, Journal of Clinical Oncology, British Journal of Haematology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.